Trial :

Pfizer RSV and Flu Study

Age :

18 - 60 years

Trial length :

3 outpatient visits

Info :

Screening from 13th April

Respiratory syncytial virus (#RSV) is the second leading cause of respiratory illness
in older adults after the #flu, and there are no specific prevention options.
Could you help advance RSV research for you and your community by joining a
study of an investigational RSV vaccine and
flu vaccine? Healthy volunteers who are 65 years of age or older are needed.

Because RSV and influenza both occur in the Australian winter, there is a possibility that the flu vaccine and the investigational RSV vaccine may be given at the same time in the future.

By taking part, you could help us learn more about the safety of the vaccine as well as your bodys immune response when it is given at the same time as an annual flu vaccine.

If you meet the criteria for this study and would like more information, register below or call 1800 727 874.